stockrowAptarGroup, Inc.
ATR Healthcare Medical Instruments & Supplies
AptarGroup, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.8 billion, up 5.42% from fiscal 2024.
- Revenue
- +6.03%
- EPS
- −73.9%
- Free cash flow
- −16.9%
- Total debt
- +14.6%
Quarter to September 2026, against a year earlier
Follow ATR
Alert me
AptarGroup, Inc. (ATR) Revenue
AptarGroup, Inc.'s revenue for fiscal 2025 was $3.8B, up 5.42% from $3.6B in fiscal 2024. Over the twelve months to 30 September 2026 it was $4.0B. Over the past ten years it has ranged from $2.3B (fiscal 2015) to $3.8B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 10 consecutive fiscal years. AptarGroup, Inc. ranks 12th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $3.8B | 5.42% |
| FY2024 | $3.6B | 2.74% |
| FY2023 | $3.5B | 4.97% |
| FY2022 | $3.3B | 2.94% |
| FY2021 | $3.2B | 10.17% |
| FY2020 | $2.9B | 2.43% |
| FY2019 | $2.9B | 3.44% |
| FY2018 | $2.8B | 11.97% |
| FY2017 | $2.5B | 5.94% |
| FY2016 | $2.3B | 0.59% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.0B | (0.72%) |
| Jun 2026 | $1.0B | 4.44% |
| Mar 2026 | $982.9M | 2.09% |
| Dec 2025 | $962.7M | 0.17% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| BAX Baxter International Inc. compare | $11.6B |
| SOLV Solventum Corporation compare | $8.2B |
| AVTR Avantor, Inc. compare | $6.6B |
| BLCO Bausch + Lomb Corporation compare | $5.4B |
| COO The Cooper Companies, Inc. compare | $4.2B |
| ALGN Align Technology, Inc. compare | $4.2B |
| ATR AptarGroup, Inc. | $4.0B |
| TFX Teleflex Incorporated compare | $2.3B |
| RGEN Repligen Corporation compare | $805.6M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on ATR
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement